Monitor Anastasiou's integration into the executive team and his impact on operational execution. The leadership changes suggest a strategic shift toward strengthening operational capabilities, which could influence future growth initiatives.
Price Chart
Executive Summary
Harmony Biosciences appointed Peter Anastasiou as Chief Operating Officer and board member Troy Ignelzi, while two directors, including Anastasiou and Antonio Gracias, stepped down. The company disclosed Anastasiou's employment agreement with a $600,000 base salary and $3.7 million equity grant.
Key Facts
- Peter Anastasiou appointed as Senior Executive Vice President and Chief Operating Officer effective April 2, 2026
- Anastasiou resigned from the board of directors upon becoming COO
- Troy Ignelzi appointed to the board to fill Anastasiou's vacancy
- Antonio Gracias will not stand for re-election at the upcoming annual meeting
- Anastasiou's employment agreement includes $600,000 annual base salary
- Anastasiou received an option grant with $3.7 million grant date fair value
- Anastasiou will receive severance equal to one year of base salary if terminated without cause
Financial Impact
The company committed to $600,000 annual cash compensation and $3.7 million in equity compensation for the new COO
Risk Factors
- Potential disruption from leadership transition
- Increased compensation expenses from new executive hire
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-038888 |
| Document: hrmy-20260331x8k.htm | 0001104659-26-038888 |
| Document: hrmy-20260331xex99d1.htm | 0001104659-26-038888 |
| Document: 0001104659-26-038888-index-headers.html | 0001104659-26-038888 |
| Document: 0001104659-26-038888-index.html | 0001104659-26-038888 |
| Document: 0001104659-26-038888.txt | 0001104659-26-038888 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 8w ago | 8-K | $38.78 $39.52 | ▲ +1.91% | ▲ +2.01% | $40.53 (+4.53%) |
Aug 4, 2026 8w ago | Press Release | $38.78 $39.52 | ▲ +1.91% | ▲ +2.01% | $40.53 (+4.53%) |
Jul 16, 2026 11w ago | 8-K | $33.53 $35.80 | ▲ +6.77% | ▲ +8.44% | $40.53 (+20.89%) |
Jun 30, 2026 13w ago | 144 | $36.00 $38.26 | ▼ −6.28% | ▼ −6.02% | $40.53 (−12.60%) |
Jun 24, 2026 14w ago | 144 | $34.13 $36.00 | ▼ −5.48% | ▼ −3.92% | $40.53 (−18.77%) |
Jun 9, 2026 16w ago | 144 | $35.48 $33.83 | ▼ −4.65% | ▼ −8.08% | $40.53 (+14.25%) |
Jun 5, 2026 16w ago | 144 | $32.39 $34.18 | ▲ +5.53% | ▲ +3.41% | $40.53 (+25.15%) |
May 19, 2026 19w ago | 3 | $30.44 $30.76 | ▲ +1.05% | ▼ −1.25% | $40.53 (+33.16%) |
May 7, 2026 21w ago | 8-K | $31.42 $30.83 | ▼ −1.88% | ▼ −3.38% | $40.53 (+29.01%) |
Apr 14, 2026 24w ago | 8-K | $29.29 $32.14 | ▲ +9.73% | ▲ +8.34% | $40.53 (+38.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access